In contrast, such neprilysin and SR-B1 changes no longer occurred in the astrocytes derived from long-standing AD patients due to a defective regulation of Aβ-clearing genes that could advance the progression of AD neuropathology. This evidence concerns the gene MME and Alzheimer disease.